T. Szabó

发表

Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.

T. Bíró, G. Balla, T. Szabó, 2015, Acta physiologica Hungarica.

Biochemical Properties of the Ligand-binding 20-kDa Subunit of the -Glucan Receptors on Human Mononuclear Phagocytes (*)

T. Szabó, J. Czop, J. Kadish, 1995, The Journal of Biological Chemistry.

Human podocytes express functional thermosensitive TRPV channels

T. Bíró, B. Tóth, T. Szabó, 2017 .

Endocannabinoid Tone Regulates Human Sebocyte Biology.

C. Zouboulis, T. Bíró, J. Gertsch, 2018, The Journal of investigative dermatology.

IPAC2021 — 12th International Particle Accelerator Conference Campinas, SP, Brazil 24-28 May 2021

T. Szabó, I. C. Moraes, F. A. B. Neto, 2021 .

N-[4-(methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: analysis of structure-activity relationships for the "C-Region".

Jeewoo Lee, P. Blumberg, L. Pearce, 2004, Bioorganic & medicinal chemistry.

N-(3-Acyloxy-2-benzylpropyl)-N'-(4-hydroxy-3-methoxybenzyl) thiourea derivatives as potent vanilloid receptor agonists and analgesics.

P. Blumberg, V. Marquez, S Y Kim, 2001, Bioorganic & medicinal chemistry.

Analysis of structure-activity relationships for the 'A-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as TRPV1 antagonists.

Vladimir A. Pavlyukovets, S. Y. Kim, Jeewoo Lee, 2005, Bioorganic & medicinal chemistry letters.

Analysis of structure-activity relationships for the 'B-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]-thiourea analogues as TRPV1 antagonists.

Vladimir A. Pavlyukovets, Jiyoun Lee, S. Y. Kim, 2005, Bioorganic & medicinal chemistry letters.

N-(3-acyloxy-2-benzylpropyl)-N'-dihydroxytetrahydrobenzazepine and tetrahydroisoquinoline thiourea analogues as vanilloid receptor ligands.

P. Blumberg, J. Lee, T. Szabó, 2001, Bioorganic & medicinal chemistry.

Distinct features of recombinant rat vanilloid receptor-1 expressed in various expression systems

P. Blumberg, T. Bíró, L. Kovács, 2003, Cellular and Molecular Life Sciences CMLS.

Thapsigargin binds to and inhibits the cloned vanilloid receptor-1.

P. Blumberg, Yun Wang, N. Kedei, 2002, Biochemical and biophysical research communications.

A non‐pungent triprenyl phenol of fungal origin, scutigeral, stimulates rat dorsal root ganglion neurons via interaction at vanilloid receptors

P. Blumberg, T. Bíró, A. Szallasi, 1999, British journal of pharmacology.

Ligand-induced Dynamic Membrane Changes and Cell Deletion Conferred by Vanilloid Receptor 1*

M. Iadarola, R. Fields, P. Blumberg, 2001, The Journal of Biological Chemistry.

Ectopic expression of the human adenine nucleotide translocase, isoform 3 (ANT-3). Characterization of ligand binding properties.

Soumitra S Ghosh, C. Anderson, Robert E Davis, 2005, Mitochondrion.

The Analgesic Drug, Tramadol, Acts as an Agonist of the Transient Receptor Potential Vanilloid-1

T. Bíró, B. Tóth, G. Czifra, 2008, Anesthesia and analgesia.

Pharmacological characterization of vanilloid receptor located in the brain.

M. Palkovits, P. Blumberg, T. Bíró, 2002, Brain research. Molecular brain research.

Protein kinase C isoforms have differential roles in the regulation of human sebocyte biology.

R. Paus, C. Zouboulis, T. Bíró, 2012, The Journal of investigative dermatology.

Human podocytes express functional thermosensitive transient receptor potential vanilloid (TRPV) channels

T. Bíró, B. Tóth, T. Szabó, 2017 .

Analysis of the Native Quaternary Structure of Vanilloid Receptor 1* 210

Peter M. Blumberg, Michael J. Iadarola, M. Iadarola, 2001, The Journal of Biological Chemistry.

High affinity antagonists of the vanilloid receptor.

Jiyoun Lee, P. Blumberg, Y. Suh, 2002, Molecular pharmacology.

High-affinity partial agonists of the vanilloid receptor.

P. Blumberg, A. Tóth, Richard Tran, 2003, Molecular pharmacology.

Structure-activity relationships of simplified resiniferatoxin analogues with potent VR1 agonism elucidates an active conformation of RTX for VR1 binding.

S. Y. Kim, Jeewoo Lee, P. Blumberg, 2004, Bioorganic & medicinal chemistry.

Functional Analysis of Capsaicin Receptor (Vanilloid Receptor Subtype 1) Multimerization and Agonist Responsiveness Using a Dominant Negative Mutation

Hong Wang, P. Blumberg, E. Kuzhikandathil, 2001, The Journal of Neuroscience.

Epidural resiniferatoxin induced prolonged regional analgesia to pain

M. Iadarola, P. Blumberg, T. Szabó, 1999, Brain Research.

Resiniferatoxin‐type phorboid vanilloids display capsaicin‐like selectivity at native vanilloid receptors on rat DRG neurons and at the cloned vanilloid receptor VR1

P. Blumberg, T. Bíró, A. Szallasi, 1999, British journal of pharmacology.

Sensitization of recombinant vanilloid receptor-1 by various neurotrophic factors.

P. Blumberg, T. Bíró, L. Kovács, 2004, Life sciences.

Inhibition of TRPC6 by protein kinase C isoforms in cultured human podocytes

L. Csernoch, M. Saleem, T. Bíró, 2015, Journal of cellular and molecular medicine.

Human podocytes express functional thermosensitive TRPV channels

T. Bíró, B. Tóth, T. Szabó, 2017, British journal of pharmacology.